SCHEMBL19341891

SCHEMBL19341891

O=C1c2ccccc2C(=O)N1OP(=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ MEN1 O00255 3/20 0.39
▸ VDR P11473 1/20 0.38
▸ EHMT2 Q96KQ7 1/20 0.37
▸ EHMT1 Q9H9B1 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA2 P00918 1/20 0.35
▸ CA4 P22748 1/20 0.35
▸ CA5A P35218 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19341894 0.85 ALDH1A1 (0.44) ELANEALDH1A1KMT2AMAPTKDM4E
SCHEMBL19341908 0.79 GAA (0.48) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL29136527 0.77 PARL (0.46) ELANEALDH1A1KMT2AKDM4EL3MBTL1
SCHEMBL19341904 0.76 GAA (0.46) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL19341895 0.74 SRC (0.47) ELANEALDH1A1KMT2AMAPTKDM4E
SCHEMBL19341883 0.74 GAA (0.41) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL11563803 0.71 GAA (0.44) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL20768726 0.69 GAA (0.56) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL262472 0.69 GAA (0.56) ALDH1A1KMT2AMAPTKDM4EHPGD
SCHEMBL19341893 0.69 GAA (0.43) ALDH1A1MAPTKDM4EGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544284-B2 Use of phosphorous-containing organic oxyimides as flame retardants and/or as stabilizers for plastics, flame-retardant and/or stabilized plastic compositions, method for the production thereof, moulded part, paint and coatings Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2020-01-28 — — US disclosed
US-20170260366-A1 USE OF PHOSPHOROUS-CONTAINING ORGANIC OXYIMIDES AS FLAME RETARDANTS AND/OR AS STABILIZERS FOR PLASTICS, FLAME-RETARDANT AND/OR STABILIZED PLASTIC COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF, MOULDED PART, PAINT AND COATINGS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2017-09-14 — — US disclosed
US-20170260366-A1 USE OF PHOSPHOROUS-CONTAINING ORGANIC OXYIMIDES AS FLAME RETARDANTS AND/OR AS STABILIZERS FOR PLASTICS, FLAME-RETARDANT AND/OR STABILIZED PLASTIC COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF, MOULDED PART, PAINT AND COATINGS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2017-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260366-A1 USE OF PHOSPHOROUS-CONTAINING ORGANIC OXYIMIDES AS FLAME RETARDANTS AND/OR AS STABILIZERS FOR PLASTICS, FLAME-RETARDANT AND/OR STABILIZED PLASTIC COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF, MOULDED PART, PAINT AND COATINGS PFAS, FERMT2, PGM2 ELANE 4434/4885ALDH1A1 1024/4885KMT2A 804/4885
US-10544284-B2 Use of phosphorous-containing organic oxyimides as flame retardants and/or as stabilizers for plastics, flame-retardant and/or stabilized plastic compositions, method for the production thereof, moulded part, paint and coatings PFAS, FERMT2, PGM2 ELANE 4434/4885ALDH1A1 1024/4885KMT2A 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback